Specials more

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Achievement first of two steps, paves way to complete approval for this very important target market

Final regulatory approval from EU for active ingredient in Timorex Gold®

Israel’s Stockton Group, which specializes in innovative plant extract based crop protection products, announces that the active ingredient in the company's flagship product Timorex Gold® - received final EU approval to be included in Annex1 (certificate relating to the level of the active ingredient in the product).

Stockton is now undergoing the second phase, called Annex 3, relating to the final product. This process is expected to be completed in 2017. Stockton expects to receive 10 years’ protection commencing once the product is finally approved.

Ziv Tirosh, CEO of the Stockton Group, stated: “EU approval is an important milestone for Timorex Gold®.This is a significant confirmation of our product’s platform, paving the way for the flow of our new and innovative products and for sustainable crop protection. Very few companies attempt to obtain these EU certifications because of the high hurdle involved, and the long, very complex and expensive process. More than that, even fewer companies are successful because of the knowledge and level required. European market certification is extremely important for our product, and we anticipate a great commercial future for our product in this significant market."

Timorex Gold® is a plant extract-based, bio-fungicide, approved for use in organic and conventional agriculture in over 25 countries, including most countries of Central and South America, Australia, Canada, the Philippines and Serbia.

Timorex Gold® is a broad-range bio-fungicide, active on a variety of diseases in many crops such as bananas, grapes, tomatoes, cucumbers, etc.

For more information:
Judy Jamuy
Tel: +972 72 257 0012

Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.